SCHEMBL3167264

SCHEMBL3167264

CC(O)(CCC(C)(O)c1ccccc1S(=O)(=O)c1ccc(C=Cc2ccc(F)cc2F)cc1)c1ccccc1S(=O)(=O)c1ccc(C=Cc2ccc(F)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 13/20 0.61
HTR2C P28335 11/20 0.61
KCNH2 Q12809 9/20 0.61
CYP2D6 P10635 1/20 0.51
NFE2L2 Q16236 4/20 0.48
PTGS1 P23219 2/20 0.42
PTGS2 P35354 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3167252 0.90 HTR2A (0.65) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3167270 0.90 HTR2A (0.65) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3151871 0.89 HTR2A (0.66) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3151857 0.89 HTR2A (0.66) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL13770758 0.80 HTR2A (0.69) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3157527 0.79 HTR2A (0.62) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3157531 0.79 HTR2A (0.62) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3158159 0.79 CYP2D6 (0.77) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3158154 0.79 CYP2D6 (0.77) HTR2AHTR2CKCNH2CYP2D6NFE2L2
SCHEMBL3166649 0.78 HTR2A (0.80) HTR2AHTR2CKCNH2CYP2D6NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786768-A1 ARYLSULPHONYLSTILBENE DERIVATIVES FOR TREATMENT OF INSOMNIA AND RELATED CONDITIONS Merck Sharp & Dohme Limited (GB) 2007-05-23 EP claimed
WO-2006021806-A1 ARYLSULPHONYLSTILBENE DERIVATIVES FOR TREATMENT OF INSOMNIA AND RELATED CONDITIONS MERCK SHARP & DOHME LIMITED (GB) 2006-03-02 WO claimed
EP-1807393-B1 DIARYLSULFONES AS 5-HT2A ANTAGONISTS MERCK SHARP & DOHME (GB) 2010-03-31 EP disclosed